SUMMARY A simple test is described for identifying patients with abnormalities of muscle energy metabolism secondary to mitochondrial dysfunction, based on the venous lactate response to exercise at 90% of predicted work rate at the anaerobic threshold. The test was standardised for age, weight and sex of subjects, and was abnormal in all cases of mitochondrial cytopathy tested, with a false positive rate of 7% in a control population. The test was abnormal in two cases of mitochondrial disease in which muscle biopsy was normal or showed only non-specific changes.
The wide clinical spectrum of disorders related to biochemical and structural abnormalities of the mitochondria is being increasingly recognised. These disorders can present with progressive muscle weakness, particularly of the extra-ocular muscles, exertional myalgia, central and peripheral nervous system dysfunction and symptoms secondary to periodic lactic acidosis; other organ systems such as the heart, liver, kidneys, the haemopoetic system, and endocrine glands may also be involved.'"3 Investigations to confirm the diagnosis of mitochondrial cytopathy typically include measurements of serum muscle enzymes, plasma lactate, electromyography, and muscle biopsy (histology, histochemistry and electron microscopy), but further investigations such as assays of specific components of the respiratory chain,4 3'P-magnetic resonance spectroscopy of muscle,5 and positron emission tomography of brain6 may be required to establish the diagnosis and to define the metabolic defect. However, such tests are complex and expensive and it is therefore important that a simple screening test is available to allow appropriate selection of cases for further investigation.
A number of defects have been identified in the aerobic utilisation of pyruvate via acetyl CoA, the citric acid cycle and the respiratory chain in the mitochondrial cytopathies'-3 and a common consequence of such defects is the secondary increased Accepted 22 March 1989 conversion of pyruvate to lactate through anaerobic glycolysis. Resting lactate levels in such patients are often normal, however,' and exercise may be required to demonstrate this abnormality. Although exercise testing is regularly performed in the investigation of mitochondrial disorders, published protocols do not clearly state the workload. Exercise regimens have ranged from minutes7 to several hours8 in duration, and from "light work" to "exercise to exhaustion", and have not been standardised with regard to age, weight and sex of subjects.
The plasma lactate concentration depends on the balance between lactate production and removal by the tissues, including muscle.9 When exercise work rate is increased incrementally, a point is reached at which lactate level rises sharply. This essentially corresponds to the anaerobic threshold (AT) in terms of oxygen consumption'" (although the lactate and oxygen utilisation responses during exercise are in fact independent" 12). AT has been measured in normal untrained volunteers during incremental exercise testing using ventilatory variables'3 4 and lactate concentrations,'0 and tables based on such measurements allow the work rate and heart rate at the AT to be predicted (table 1) . We elected to exercise subjects at a steady state below their predicted AT, on the premise that rises in venous lactate in normal people at such work rates should be of small magnitude, whereas a decrease in AT, as might be anticipated in patients with mitochondrial cytopathy, should lead to an abnormally large rise. In this paper, we describe the sub-anaerobic threshold exercise test (SATET) and our preliminary results in 29 normal volunteers, and in six patients with mitochondrial cytopathies. 1090 Post-exercise lactate levels were significantly lower in normal males than females, but levels in the patients were significantly higher than controls irrespective of age or sex. The 30' post-exercise lactate levels were comparable in males and females, but were significantly greater in the patients than in the controls. Table 4 shows the means and upper 99% confidence limits for the control groups.
Only 2/29 controls had a peak lactate greater than 5 mM (fig 1) . These two subjects were both female, and aged 43 and 49 years. Using 5 mM as a convenient "cut-off" for the normal upper limit for peak lactate in the test, the sensitivity (positivity in disease) in the patients with mitochondrial cytopathy was 100% and the specificity (negativity in health) was 93%. While 30' post-exercise lactate levels tended to be higher in patients than controls, there was considerable overlap between the two groups and these measurements did not provide sufficient discrimination in individual cases. Table 2 Additional clinical and laboratory data in CPEO-plus patients Figure 2 shows the (mean-predicted) heart rates for both patients and controls during exercise. A linear correlation relating these variables was found (r = 0755, p < 0O001). In the majority of subjects, the differences were small (less than 15 The diagnosis of mitochondrial cytopathy and identification of the biochemical defect in these patients is of more than academic importance. The clinical and pathological consequences of the metabolic disorder progress with time,"5 but some cases respond to treatment with thiamine, '6 riboflavin" or Coenzyme Q."8 While the diagnostic "gold standard" for mitochondrial cytopathies remains that ofa positive muscle biopsy, characterised by sub-sarcolemmal accumulations of abnormal mitochondria on oxidative enzyme staining and electron microscopy,'"3 biopsy may show no abnormalities in routine histological and histochemical preparations.'"2' The diagnosis in our patients was made on the basis of clinical presentation and supportive laboratory investigations, but it should be noted that not all patients had abnormal muscle biopsies. Case 3, for example, had only minor nonspecific abnormalities on biopsy, but presented with an identical clinical picture to that of her brother (case 2), whose biopsy specimen showed changes typical ofa mitochondrial myopathy.
The main advantage of the SATET in the diagnosis of disorders of energy metabolism is its simplicity and high sensitivity under standardised conditions, using defined work rates. Johnson et al t2 exercised subjects at "30% ofmaximal work rate" and measured venous lactate at rest and at 5 and 15 minutes in one patient with CPEO plus and five controls; little change was recorded in post-exercise levels. Morgan-Hughes et al 'used an exercise test which consisted of "pedalling a standard exercise ergometer without added load for a period of five or fifteen minutes at a rate of approximately 10 km/hr". An ""appropriate" exercise time and work load was then selected following a series of trials. In a subsequent report,2 the work load was adjusted to produce a heart rate of "approximately 150 beats/minute", with venous lactate samples being taken at 5 minute intervals during exercise and at 5, 15, 30, 45 and 75 minutes after exercise. The maximum peak exercise lactate concentration in 14 normal and disease controls was 1-8 mM. In 19/29 patients with mitochondrial myopathies, peak lactate concentrations rose to 2 mM or greater, but remained below this level in the other 10 cases, giving a test sensitivity of 66%. Using the regime described here, all cases of mitochondrial cytopathy had peak lactates greater than 5 mM, and the specificity of the test at this level was 93%.
Subjects showing abnormal peak lactate levels also had mean heart rates which were substantially above predicted rates at AT (fig 2) . This "hyperkinetic circulatory response" in patients with presumed defects in muscle oxidative phosphorylation was recognised in early studies of patients with limited exercise tolerance and increased lactate and pyruvate concentrations in the blood, and was shown to be a cardiovascular response to vasodilatation and arteriovenous shunting in the muscles, presumably induced by excessive accumulation of metabolites. 22 Obviously, an abnormal result on such a test cannot be considered specific for metabolic muscle disease. An increased plasma lactate response to exercise might occur under other circumstances, such as impaired oxygen delivery to the muscles in anaemia or cardiorespiratory disease.'2 Lactate production by muscle is also influenced by cardiovascular fitness and training. Aerobic training increases AT, decreasing the amount of lactate released at a given workload. 23 We did not rigorously assess the amount of leisure-time exercise undertaken by our controls but none were in regular training, and were in this respect comparable to the patients, all of whom were mobile and active. An abnormal result might also arise if there was reduced re-uptake of released lactate by muscle, in patients with reduced muscle bulk. We have studied three patients with motor neuron disease; one with limited mobility and significant muscular atrophy had an abnormal peak lactate of 5-7 mM, but two other less disabled patients had normal results.
Although non-specific, the SATET may be more sensitive than standard muscle biopsies for the diagnosis of mitochondrial cytopathies in cases of progressive external ophthalmoplegia. Whether it will be as useful in cases with predominantly central nervous system involvement is uncertain. We have studied two such cases, aged 26 and 30 years, where the diagnosis was suspected but not confirmed on biopsy. One had Ramsay Hunt syndrome (dyssynergia cerebellaris myoclonica), which has recently been shown to be a mitochondrial cytopathy by 3'P-NMR spectroscopy,24 and the other an undefined disorder characterised by marked exercise intolerance, intermitten encephalopathy with lactic acidaemia and raised serum creatine kinase levels, migrainous headaches, short stature and mild mental retardation. Both had abnormal peak lactate levels of 8-2 and 7-4 mM respectively, in the SATET.
The test might also find a role in the evaluation of chronic fatigue and myalgia. These are common and sometimes disabling symptoms, which, since even detailed investigation rarely defines a cause,25 are often considered to be psychogenic. Yet 
